Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
FTC Sues CVS Health, Cigna And United Health Group For Inflating Insulin Prices
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's
Feds sue pharmacy gatekeepers over high insulin costs
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming they are illegally maximizing profits by steering patients to high-cost insulin products.
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
FTC goes after drug middlemen for allegedly jacking up insulin prices
The Big Three handle at least 80% of the country’s insulin prescriptions. The price of insulin has exponentially increased in recent years. Now, the Federal Trade Commission (FTC) is suing three companies over allegedly inflating the cost of the drug at the expense of Americans who rely on it.
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
American Pharmacists Association applauds FTC action on PBMs' alleged inflation of insulin drug prices
Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission's (FTC) action today against alleged practices by large vertically integrated pharmacy benefit managers (PBMs) "for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
FTC Sues CVS, Cigna, UnitedHealth Over Insulin Costs
Bloomberg's Tyler Kendall breaks down the latest in the suit accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin. (Source: Bloomberg)
IJR19h
Biden-Harris FTC Accuses Major Healthcare Companies Of Artificially Inflating Drug Prices In New Lawsuit
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
CVS Health Corp. stock underperforms Friday when compared to competitors
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Alpine woman loses $2,500 to scam
ALPINE, Texas — There's a woman who fell victim to a CVS scam in Alpine. The Alpine Police Department got a call about it ...
Benefits Pro2d
CVS' Oak Street Health will pay $60 million to settle federal kickback allegations
The Anti-Kickback Statute prohibits anyone from offering or paying, directly or indirectly, money or anything else of value ...
Morningstar2d
CVS Health Corp
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
CVS Health announces quarterly dividend
CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The ...
Wawa stakes its claim in Sheetz territory with its first Central Pa. store
Hundreds of Wawa fans screamed, danced, and skipped their way into the grand opening of Wawa's Middletown store Thursday.
Palo Alto Weekly10d
Police: Man arrested for attack at CVS
A San Jose man was arrested Monday afternoon for assaulting another man during a robbery next to a CVS store in downtown Palo ...
AOL2d
UnitedHealth, CVS Caremark, Express Scripts sued by FTC over skyrocketing insulin prices
The case accuses UnitedHealth Group’s Optum unit, CVS Health’s CVS Caremark and Cigna’s Express Scripts of unfairly excluding lower cost insulin products from lists of drugs covered by insurers.